Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in Detroit, Michigan · 14219 W. MC NICHOLS ROAD, DETROIT, MI 48235 · (313) 836-1850
Part of Exelixis Clinical
As of July 2026, 1 paid clinical trial is recruiting at Exelixis Clinical in Detroit, Michigan. Active studies at this site cover conditions such as Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Urothelial Carcinoma (UC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (1)
More research sites in Detroit
- Henry Ford Hospital (142 trials)
- Karmanos Cancer Institute (86 trials)
- Henry Ford Health System (73 trials)
- Henry Ford Health (55 trials)
- Children's Hospital of Michigan (41 trials)
- Henry Ford Health Saint John Hospital (37 trials)
- Wayne State University/Karmanos Cancer Institute (30 trials)
- Wayne State University (21 trials)
- Barbara Ann Karmanos Cancer Institute (16 trials)
- Henry Ford Cancer Institute (11 trials)
Explore more
Paid clinical trials in Detroit, MI · Michigan clinical trials